Evidence map›Paper›PMID 25299049›Full record

ArticlePloS one2014

Myeloid ZFP36L1 does not regulate inflammation or host defense in mouse models of acute bacterial infection.

Lynnae D Hyatt, Gregory A Wasserman, Yoon J Rah, Kori Y Matsuura, Fadie T Coleman, Kristie L Hilliard, Zachary Ash Pepper-Cunningham, Michael Ieong, Deborah J Stumpo, Perry J Blackshear and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Hallmarks of cancer and AU-rich elements.Wiley interdisciplinary reviews. RNA · 2017
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Lynnae D HyattPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Gregory A WassermanPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Yoon J RahPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Kori Y MatsuuraPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Fadie T ColemanPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Kristie L HilliardPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Zachary Ash Pepper-CunninghamPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Michael IeongPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Deborah J StumpoLaboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, United States of America.
Perry J BlackshearLaboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, United States of America; Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina, United States of America.
Lee J QuintonPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Joseph P MizgerdPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Matthew R JonesPulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Boston University · USDuke Medical Center · USNational Institute of Environmental Health Sciences · US

Funding

TTP and related proteins in the regulation of gene expressionZIAES090080 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI BLACKSHEAR, PERRY J · 2009 to 2025
$52.6M
BIOLOGY OF THE LUNG--MULTIDISCIPLINARY PROGRAMT32HL007035 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, JOSEPH P MIZGERD · 1985 to 2026
$24.3M
NF-KB and Innate Immunity in the LungsR01HL068153 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI MIZGERD, JOSEPH P · 2003 to 2016
$5.1M
Regulation and function of STAT3 during pneumoniaR01HL079392 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI MIZGERD, JOSEPH P · 2005 to 2015
$4.0M
The Biology of LIF During PneumoniaR01HL111449 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI QUINTON, LEE · 2012 to 2020
$3.7M
MicroRNA uridylation by Zcchc11 regulates pulmonary inflammationR01HL104053 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI JONES, MATTHEW ROBERT · 2010 to 2014
$2.0M
Lung-Liver Axis During PneumoniaR00HL092956 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI QUINTON, LEE · 2010 to 2012
$745k
NHLBI NIH HHS R00 HL092956NHLBI NIH HHS R00-HL092956NHLBI NIH HHS R01 HL068153NHLBI NIH HHS R01-HL068153NHLBI NIH HHS R01 HL079392NHLBI NIH HHS R01-HL079392NHLBI NIH HHS R01 HL104053NHLBI NIH HHS R01-HL104053NHLBI NIH HHS R01 HL111449NHLBI NIH HHS R01-HL111449NHLBI NIH HHS T32 HL007035NHLBI NIH HHS T32-HL007035
6 · The paper itself

Abstract

Zinc finger protein 36, C3H type-like 1 (ZFP36L1) is one of several Zinc Finger Protein 36 (Zfp36) family members, which bind AU rich elements within 3' untranslated regions (UTRs) to negatively regulate the post-transcriptional expression of targeted mRNAs. The prototypical member of the family, Tristetraprolin (TTP or ZFP36), has been well-studied in the context of inflammation and plays an important role in repressing pro-inflammatory transcripts such as TNF-α. Much less is known about the other family members, and none have been studied in the context of infection. Using macrophage cell lines and primary alveolar macrophages we demonstrated that, like ZFP36, ZFP36L1 is prominently induced by infection. To test our hypothesis that macrophage production of ZFP36L1 is necessary for regulation of the inflammatory response of the lung during pneumonia, we generated mice with a myeloid-specific deficiency of ZFP36L1. Surprisingly, we found that myeloid deficiency of ZFP36L1 did not result in alteration of lung cytokine production after infection, altered clearance of bacteria, or increased inflammatory lung injury. Although alveolar macrophages are critical components of the innate defense against respiratory pathogens, we concluded that myeloid ZFP36L1 is not essential for appropriate responses to bacteria in the lungs. Based on studies conducted with myeloid-deficient ZFP36 mice, our data indicate that, of the Zfp36 family, ZFP36 is the predominant negative regulator of cytokine expression in macrophages. In conclusion, these results imply that myeloid ZFP36 may fully compensate for loss of ZFP36L1 or that Zfp36l1-dependent mRNA expression does not play an integral role in the host defense against bacterial pneumonia.

Indexed as

AnimalsBacterial InfectionsBronchoalveolar Lavage FluidButyrate Response Factor 1Cell LineCytokinesHumansInflammationLungMacrophagesMiceMice, Inbred C57BLMyeloid CellsNuclear ProteinsPneumonia, BacterialRNA-Binding ProteinsButyrate Response Factor 1CytokinesNuclear ProteinsRNA-Binding ProteinsRNA, MessengerZfp36l1 protein, mouse

Identifiers

PMID25299049
PMCPMC4192124
OpenAlexW2024390749

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.